AOTI awarded Federal Supply Schedule (FSS) contract, allowing for Reimbursement of it’s Topical Wound Oxygen therapy within the Veterans Administration (VA) health system and Indian Health Service (IHS)

by | Sep 1, 2009 | Press

Galway, Ireland, Sept. 1, 2009 – AOTI Ltd. announced today that it has been awarded a new contract by the General Services Administration (GSA). AOTI’s Federal Supply Schedule (FSS) contract number is V797P-4209b and the initial contract period is for 5 years....

AOTI adds Director of Sales for Germany

by | Sep 1, 2009 | Press

Galway, Ireland, Sept. 1, 2009 – AOTI Ltd. announced today that Tom Hauffe has joined the company as Director of Sales for Germany and German speaking countries. Tom started his career in the medical field as a medical Sergeant in the German Air Force. After...

Clinical Study Validates TWO2 Therapy Effectiveness

by | May 26, 2009 | Press

Galway, Ireland, May 26- AOTI announced today that a new clinical study published in the May issue of European Journal of Vascular and Endovascular Surgery demonstrates superior wound closure rates for patients suffering from refractory venous ulcers treated with its...

AOTI adds Global Medical Director

by | May 5, 2009 | Press

Galway, Ireland, May 5- AOTI, INC., announced today that Dr. Christian Frye has joined the company as its Global Medical Director and Chief Science Officer. Christian graduated from the University of Cologne, Germany in 1994 with his Medical Degree and has more than...